MINERVAX ApS
CVR 32673287 · Private limited company (ApS) · Active · Medium risk
MINERVAX ApS is a Private limited company (ApS), founded on , based in Frederiksberg. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 2.0% over the next 12 months, which is 1.4 times the average for Danish companies. 16 annual reports have been published.
Bankruptcy risk for MINERVAX ApS
2.0%
probability of bankruptcy within 12 months
Medium risk
1.4 × the average (1.41%) · higher risk than 82% of active Danish companies
Lowest riskHighest risk
Increases the risk
Number of CEOs0 · bankruptcy rate 12.7%1.4×
CEOs in total (historical)0 · bankruptcy rate 12.4%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Other companies at the same address100+ · bankruptcy rate 11.5%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×
Municipality changes3+ · bankruptcy rate 10.6%1.2×
Employees (latest year)2–5 · bankruptcy rate 10.3%1.2×
Postcode changes3+ · bankruptcy rate 10.2%1.2×
Reduces the risk
Published annual reports10+ · bankruptcy rate 3.0%0.35×
Reporting classReporting class B · bankruptcy rate 3.2%0.37×
Number of auditors (historical)3+ · bankruptcy rate 3.7%0.42×
Age (years)10–20 yrs · bankruptcy rate 3.9%0.45×
Auditor registered in CVRYes · bankruptcy rate 4.8%0.55×
Audit opted outNo · bankruptcy rate 4.8%0.55×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
Registered owners4+ · bankruptcy rate 5.7%0.65×
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 32673287
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (16 years)
- Address
- Nordre Fasanvej 215
2000 Frederiksberg - Municipality
- Frederiksberg
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 25.1m
- Employees
- 2 (2018)
- Auditor
- EY Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 16 |
| Missing annual report | No |
| Negative equity | – |
| Equity ratio | – |
| Current ratio | – |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 111 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|
Latest annual report: Reporting class B · auditor's statement: Auditor's report on audited financial statements · EY Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 181 | ||
| 1 Jan 2024 – 31 Dec 2024 | 157 | ||
| 1 Jan 2023 – 31 Dec 2023 | 151 | ||
| 1 Jan 2022 – 31 Dec 2022 | 156 | ||
| 1 Jan 2021 – 31 Dec 2021 | 122 | ||
| 1 Jan 2020 – 31 Dec 2020 | 179 | ||
| 1 Jan 2019 – 31 Dec 2019 | 73 | ||
| 1 Jan 2018 – 31 Dec 2018 | 99 | ||
| 1 Jan 2017 – 31 Dec 2017 | 82 | ||
| 1 Jan 2016 – 31 Dec 2016 | 135 | ||
| 1 Jan 2015 – 31 Dec 2015 | 81 | ||
| 1 Jan 2014 – 31 Dec 2014 | 61 | ||
| 1 Jan 2013 – 31 Dec 2013 | 121 | ||
| 1 Jan 2012 – 31 Dec 2012 | 154 | ||
| 1 Jan 2011 – 31 Dec 2011 | 159 | ||
| 14 Jan 2010 – 31 Dec 2010 | 158 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| Board | Sten Verland | Current | |
| Board | Emmanuelle Coutanceau | Current | |
| Board | Christopher J. Gagliardi | Current | |
| Board | Kabeer Aziz | Current | |
| Board | Bita Sehat | Current | |
| Board | Vincent Guy A. Brichard | Current | |
| Board | Tal Zvi Zaks | Current | |
| Board | Patrik Sobocki | Current | |
| Board | Veronica Gambillara Fonck | Current | |
| Board | Varun Kumar Gupta | Current | |
| Board | Mona Annelie Sylvén Troedsson | ||
| Board | Carl Gunnar Lindahl | ||
| Board | Carl Gunnar Lindahl | ||
| Board | Lars Thomas Joakim Areschoug | ||
| Board | Ole Bitsch-Jensen | ||
| Board | Steen Søren Klysner | ||
| Board | Line Holten Reimer | ||
| Board | Ingelise Saunders | ||
| Board | Nanna Liebach Lüneborg | ||
| Board | Carl Fredrik Siwmark | ||
| Board | Carsten Schou | ||
| Board | Bent Østergaard | ||
| Board | Tommy Thomsen | ||
| Board | Karl Nägler | ||
| Board | Bita Sehat | ||
| Board | Dr. Gerd Werner Zettlmeissl | ||
| Board | Patrik Georg Andlin Sobocki | ||
| Board | Jonas Karl Olof Brambeck | ||
| Board | Veronica Gambillara Fonck | ||
| Board | Regina Hodits | ||
| Owner (15%) | Novo Holdings A/S | Current | |
| Owner (5%) | SUNSTONE LIFE SCIENCE VENTURES FUND III K/S | Current | |
| Owner (5%) | Adjuvant Global Health Technology Fund, L.P. | Current | |
| Owner (5%) | Wellington Partners Life Sciences V GmbH & Co. KG | Current | |
| Owner (5%) | Sanofi Foreign Participations B.V. | Current | |
| Owner (5%) | Stiftelsen Industrifonden | Current | |
| Owner (5%) | Trill Impact Ventures Tech 1 S.à rl | Current | |
| Owner (10%) | BB Pureos Bioventures, LP | Current | |
| Owner (5%) | OrbiMed Private Investments IX, LP | Current | |
| Owner (15%) | LSP 7 Coöperatief U.A. | Current | |
| Owner (5%) | PreSeed Ventures A/S | ||
| Owner (10%) | Lunds Universitets Innovationssystem Aktiebolag (LUIS AB) | ||
| Owner (10%) | Lauritzen Fonden Holding ApS | ||
| Owner (33%) | Novo Holdings A/S | ||
| Owner (10%) | SUNSTONE LIFE SCIENCE VENTURES FUND III K/S | ||
| Owner (15%) | Lauritzen Fonden Holding ApS | ||
| Owner (33%) | Novo Holdings A/S | ||
| Owner (15%) | SUNSTONE LIFE SCIENCE VENTURES FUND III K/S | ||
| Owner (5%) | Lunds Universitets Innovationssystem Aktiebolag (LUIS AB) | ||
| Owner (15%) | Lauritzen Fonden Holding ApS | ||
| Owner (33%) | Novo Holdings A/S | ||
| Owner (15%) | SUNSTONE LIFE SCIENCE VENTURES FUND III K/S | ||
| Owner (5%) | Lauritzen Fonden Holding ApS | ||
| Owner (10%) | SUNSTONE LIFE SCIENCE VENTURES FUND III K/S | ||
| Owner (5%) | Wellington Partners Life Sciences V GmbH & Co. KG | ||
| Owner (5%) | Sanofi Foreign Participations B.V. | ||
| Owner (5%) | Stiftelsen Industrifonden | ||
| Owner (5%) | Adjuvant Global Health Technology Fund, L.P. | ||
| Owner (10%) | Wellington Partners Life Sciences V GmbH & Co. KG | ||
| Owner (10%) | Sanofi Foreign Participations B.V. | ||
| Owner (10%) | Stiftelsen Industrifonden | ||
| Owner (10%) | Adjuvant Global Health Technology Fund, L.P. | ||
| Owner (10%) | Trill Impact Ventures Tech 1 S.à rl | ||
| Auditor | EY Godkendt Revisionspartnerselskab | Current | |
| Auditor | PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab | ||
| Auditor | VERAX | ||
| Auditor | ATHOS STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | AIDER Godkendt Revisionsaktieselskab | ||
| Founder | Lars Thomas Joakim Areschoug | Current | |
| Founder | Carl Gunnar Lindahl | Current | |
| Founder | Eskil Johnsson | Current | |
| Founder | Johan Waldemarsson | Current | |
| Founder | Lund Universitets Utvecklingsaktiebolag | Current | |
| Founder | Margaretta Stålhammer-Carlemalm | Current |
Address history (3 moves)
| Nordre Fasanvej 215, 2000 Frederiksberg | |
| Ole Maaløes Vej 3, 2200 København N | |
| Vedbendvej 28, 2900 Hellerup | |
| c/o Seed Capital Denmark, Diplomvej 381, 2800 Kgs.Lyngby |
Employees per year
Other companies at the same address
- Nordetect ApS Bankrupt
- ACESION PHARMA ApS Active
- AdaptVac ApS Active
- Adcendo ApS Active
- Akylox Therapeutics ApS Active
- Antraka ApS Opløst
- Augustine Therapeutics Denmark ApS Active
- Autocert ApS Active
- Avancert ApS Active
- B4C ApS Active
- BOOST Pharma ApS Active
- Baekmark IP Consult ApS Active
- Betula Capital ApS Active
- BioPhenyx ApS Active
- Biobridge Partners ApS Active
- Biotinia ApS Active
- CMCAssist ApS Active
- CMCGreenhouse ApS Active
- CMCHoldings ApS Active
- CaMaRa ApS Active
- Catalyst Vaccination A/S Active
- Chris Cording Jønsson Holding ApS Active
- DARERL ApS Active
- DFY ApS Active
- DeltaBot ApS Active
Similar companies in Frederiksberg
- Catalyst Vaccination A/S Frederiksberg
- RefuelBio ApS Frederiksberg
- BioMomentum Advisors ApS Frederiksberg
- Oak Mountain Consulting ApS Frederiksberg
- Biotinia ApS Frederiksberg
- Nordic BioVentures ApS Frederiksberg C
- Zevra Denmark A/S Frederiksberg
- BioPhenyx ApS Frederiksberg
- BioSpringbok ApS Frederiksberg
- Orbis Medicines ApS Frederiksberg
- Epoqe Pharma ApS Frederiksberg
- SJM IP ApS Frederiksberg C
Questions and answers about MINERVAX ApS
Has MINERVAX ApS gone bankrupt?
No, MINERVAX ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of MINERVAX ApS?
Our model estimates a bankruptcy risk of 2.0% over the next 12 months (medium risk), which is 1.4 times the average for Danish companies.
Who is the auditor of MINERVAX ApS?
MINERVAX ApS most recently used EY Godkendt Revisionspartnerselskab.
When was MINERVAX ApS founded?
MINERVAX ApS was founded on 14 January 2010.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.